New CAR-T Therapy CB-010, Granted Two FDA Designations And Three Patients Are Cancer-Free For Six Months!

New Findings Confirm: Excellent Data On This Bipotent Antibody Drug Against Ovarian Cancer!

Royal Brompton Hospital

Why Is Astrazeneca Willing To Spend a Whopping $12.1 Billion?

How Confirm The Diagnosis Of Highly Differentiated Cholangiocarcinoma With Lymph Node Metastasis? How To Treat Highly Differentiated Cholangiocarcinoma With Metastatic Lymph Nodes?

FDA Grants Orphan Drug Status To Two New Therapies In a Row, And These Two Groups Of Patients Are Expected To Benefit!